Literature DB >> 29674496

GFI1 is required for RUNX1/ETO positive acute myeloid leukemia.

Anna E Marneth1, Lacramioara Botezatu2, Judith M Hönes2,3, Jimmy C L Israël1, Judith Schütte2, Lothar Vassen2, Robert F Lams2, Saskia M Bergevoet1, Laura Groothuis1, Amit Mandoli4, Joost H A Martens4, Gerwin Huls5, Joop H Jansen1, Ulrich Dührsen2, Tobias Berg6, Tarik Möröy7, Christian Wichmann8, Mia-Chia Lo9, Dong-Er Zhang9, Bert A van der Reijden10, Cyrus Khandanpour11,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29674496      PMCID： PMC6119136          DOI： 10.3324/haematol.2017.180844

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity.

Authors:  Christian Wichmann; Yvonne Becker; Linping Chen-Wichmann; Vitali Vogel; Anna Vojtkova; Julia Herglotz; Sandra Moore; Joachim Koch; Jörn Lausen; Werner Mäntele; Holger Gohlke; Manuel Grez
Journal:  Blood       Date:  2010-04-29       Impact factor: 22.113

2.  Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1.

Authors:  Holger Karsunky; Hui Zeng; Thorsten Schmidt; Branko Zevnik; Reinhart Kluge; Kurt Werner Schmid; Ulrich Dührsen; Tarik Möröy
Journal:  Nat Genet       Date:  2002-01-28       Impact factor: 38.330

3.  Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.

Authors:  Bas J Wouters; Bob Löwenberg; Claudia A J Erpelinck-Verschueren; Wim L J van Putten; Peter J M Valk; Ruud Delwel
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

4.  Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism.

Authors:  Laura McGhee; Josh Bryan; Liza Elliott; H Leighton Grimes; Avedis Kazanjian; J Nathan Davis; Shari Meyers
Journal:  J Cell Biochem       Date:  2003-08-01       Impact factor: 4.429

5.  ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.

Authors:  Joost H A Martens; Amit Mandoli; Femke Simmer; Bart-Jan Wierenga; Sadia Saeed; Abhishek A Singh; Lucia Altucci; Edo Vellenga; Hendrik G Stunnenberg
Journal:  Blood       Date:  2012-09-14       Impact factor: 22.113

6.  Gfi1 integrates progenitor versus granulocytic transcriptional programming.

Authors:  Shane R Horman; Chinavenmeni S Velu; Aditya Chaubey; Tristan Bourdeau; Jinfang Zhu; William E Paul; Brian Gebelein; H Leighton Grimes
Journal:  Blood       Date:  2009-04-03       Impact factor: 22.113

7.  Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup.

Authors:  Marie-Anne Hospital; Thomas Prebet; Sarah Bertoli; Xavier Thomas; Emmanuelle Tavernier; Thorsten Braun; Cécile Pautas; Aurore Perrot; Bruno Lioure; Philippe Rousselot; Jérôme Tamburini; Thomas Cluzeau; Johanna Konopacki; Edouard Randriamalala; Céline Berthon; Marie-Pierre Gourin; Christian Recher; Jean-Yves Cahn; Norbert Ifrah; Hervé Dombret; Nicolas Boissel
Journal:  Blood       Date:  2014-07-08       Impact factor: 22.113

8.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.

Authors:  Masakazu Higuchi; Darin O'Brien; Parasakthy Kumaravelu; Noel Lenny; Eng-Juh Yeoh; James R Downing
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

9.  Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia.

Authors:  Cyrus Khandanpour; James D Phelan; Lothar Vassen; Judith Schütte; Riyan Chen; Shane R Horman; Marie-Claude Gaudreau; Joseph Krongold; Jinfang Zhu; William E Paul; Ulrich Dührsen; Bertie Göttgens; H Leighton Grimes; Tarik Möröy
Journal:  Cancer Cell       Date:  2013-02-11       Impact factor: 31.743

10.  Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.

Authors:  A Ptasinska; S A Assi; D Mannari; S R James; D Williamson; J Dunne; M Hoogenkamp; M Wu; M Care; H McNeill; P Cauchy; M Cullen; R M Tooze; D G Tenen; B D Young; P N Cockerill; D R Westhead; O Heidenreich; C Bonifer
Journal:  Leukemia       Date:  2012-02-20       Impact factor: 11.528
View more
  9 in total

1.  HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.

Authors:  Alba Maiques-Diaz; Luciano Nicosia; Naseer J Basma; Isabel Romero-Camarero; Francesco Camera; Gary J Spencer; Fabio M R Amaral; Fabrizio Simeoni; Bettina Wingelhofer; Andrew J K Williamson; Andrew Pierce; Anthony D Whetton; Tim C P Somervaille
Journal:  Oncogene       Date:  2022-09-28       Impact factor: 8.756

Review 2.  Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma.

Authors:  Alessandro Allegra; Marco Casciaro; Paola Barone; Caterina Musolino; Sebastiano Gangemi
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

3.  A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia.

Authors:  Yun Tan; Xiaoling Wang; Huan Song; Yi Zhang; Rongsheng Zhang; Shufen Li; Wen Jin; Saijuan Chen; Hai Fang; Zhu Chen; Kankan Wang
Journal:  Blood       Date:  2021-03-18       Impact factor: 22.113

Review 4.  Epigenetic-Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease.

Authors:  Juraj Adamik; G David Roodman; Deborah L Galson
Journal:  JBMR Plus       Date:  2019-03-15

Review 5.  Targeting the GFI1/1B-CoREST Complex in Acute Myeloid Leukemia.

Authors:  Maaike G J M van Bergen; Bert A van der Reijden
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

6.  GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival.

Authors:  Daniela N Petrusca; Patrick L Mulcrone; David A Macar; Ryan T Bishop; Evgeny Berdyshev; Attaya Suvannasankha; Judith L Anderson; Quanhong Sun; Philip E Auron; Deborah L Galson; G David Roodman
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

Review 7.  Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications.

Authors:  Tarik Möröy; Cyrus Khandanpour
Journal:  Front Oncol       Date:  2019-08-27       Impact factor: 6.244

Review 8.  Multifaceted Actions of GFI1 and GFI1B in Hematopoietic Stem Cell Self-Renewal and Lineage Commitment.

Authors:  Hugues Beauchemin; Tarik Möröy
Journal:  Front Genet       Date:  2020-10-26       Impact factor: 4.599

Review 9.  AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.

Authors:  Kai Rejeski; Jesús Duque-Afonso; Michael Lübbert
Journal:  Oncogene       Date:  2021-07-30       Impact factor: 9.867
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.